Bacteremic pneumococcal pneumonia associated with macrolide failure

Area of Science:

• Infectious Diseases
• Microbiology
• Pulmonology

Background:

• Current guidelines recommend macrolides for empiric outpatient community-acquired pneumonia (CAP).
• Rising rates of macrolide resistance in Streptococcus pneumoniae are documented.
• The clinical significance of S. pneumoniae macrolide resistance remains debated.

Observation:

• Two cases of CAP caused by S. pneumoniae are presented.
• Both cases were treated with clarithromycin, a macrolide antibiotic.
• One patient experienced treatment failure with a fatal outcome.

Findings:

• The study reports treatment failures in CAP due to S. pneumoniae despite macrolide therapy.
• These cases suggest that macrolide resistance in S. pneumoniae can have significant clinical consequences.
• The findings challenge the routine use of macrolides as first-line empiric therapy for CAP.

Implications:

• Re-evaluation of current CAP treatment guidelines may be necessary.
• Alternative empiric antibiotic choices should be considered for CAP.
• Increased surveillance for macrolide resistance in S. pneumoniae is warranted.